![]() |
|
|
|||||||
|
|
LinkBack | Thread Tools | Display Modes |
|
|||
|
Targovax, an oncology biopharma company, today announced that it has secured NOK 13 million from a consortium comprising the Radium Hospital Research Foundation, Birk Venture, RO Invest and existing owners for further development of its lead candidate, TG01, a therapeutic vaccine for pancreatic cancer.
More... |
| Thread Tools | |
| Display Modes | |
|
|